OS Therapies Incorporated (OSTX )

Currency in USD Disclaimer
$0.79 -$0.03 (-3.33%)
Open 11/20/2026
$0.79
$0.86
$1.15
$2.25

Company brief: OS THERAPIES INCORPORATED (OSTX )


OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.

OSTX Corporation News

Income Statement